Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

EMBO Molecular Medicine 2026 Open access

Read full text
Authors: Duo Xu, Yanyun Gao, Shengchen Liu, Shiyuan Yin, Tong Hu, Haibin Deng, Tuo Zhang, Balázs Hegedűs, Thomas M. Marti, Patrick Dorn, Shun‐Qing Liang, Ralph Alexander Schmid
+2 more Ren‐Wang Peng, Yongqian Shu
DOI: 10.1038/s44321-025-00366-5
Cited by: 0

Abstract

The authors notified the journal after finding an error in one of the figure panels. After reviewing the supplied source data the journal agrees to withdraw and replace Fig. EV1C.

Fields of Study & Subjects

Biochemical and Molecular Research Occupational and environmental lung diseases Cancer Hypoxia and Metabolism

Publication details

Journal / source
EMBO Molecular Medicine
Volume
18
Issue
2
Pages
851–854
Publication date
16 January 2026
Language
EN